Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

NCT01345240 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01345240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01345240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
November 17, 2011
Completion date
February 9, 2017
Enrollment
705 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria vaccines